Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
0.3638
-0.0122 (-3.24%)
At close: Sep 12, 2025, 4:00 PM EDT
0.3750
+0.0112 (3.08%)
After-hours: Sep 12, 2025, 7:53 PM EDT

Moleculin Biotech Statistics

Total Valuation

MBRX has a market cap or net worth of $13.37 million. The enterprise value is $6.23 million.

Market Cap13.37M
Enterprise Value 6.23M

Important Dates

The next estimated earnings date is Friday, November 7, 2025, after market close.

Earnings Date Nov 7, 2025
Ex-Dividend Date n/a

Share Statistics

MBRX has 36.74 million shares outstanding. The number of shares has increased by 273.43% in one year.

Current Share Class 36.74M
Shares Outstanding 36.74M
Shares Change (YoY) +273.43%
Shares Change (QoQ) +66.17%
Owned by Insiders (%) 2.84%
Owned by Institutions (%) 5.50%
Float 35.69M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.15

Current Ratio 1.15
Quick Ratio 0.96
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -503.80% and return on invested capital (ROIC) is -276.74%.

Return on Equity (ROE) -503.80%
Return on Assets (ROA) -67.42%
Return on Invested Capital (ROIC) -276.74%
Return on Capital Employed (ROCE) -185.98%
Revenue Per Employee n/a
Profits Per Employee -$1.56M
Employee Count17
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.84% in the last 52 weeks. The beta is 1.50, so MBRX's price volatility has been higher than the market average.

Beta (5Y) 1.50
52-Week Price Change -84.84%
50-Day Moving Average 0.57
200-Day Moving Average 1.10
Relative Strength Index (RSI) 33.91
Average Volume (20 Days) 4,733,800

Short Selling Information

The latest short interest is 2.76 million, so 7.53% of the outstanding shares have been sold short.

Short Interest 2.76M
Short Previous Month 3.30M
Short % of Shares Out 7.53%
Short % of Float 7.75%
Short Ratio (days to cover) 0.63

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -25.44M
Pretax Income -26.82M
Net Income -26.55M
EBITDA -25.32M
EBIT -25.44M
Earnings Per Share (EPS) -$3.15
Full Income Statement

Balance Sheet

The company has $7.56 million in cash and $420,000 in debt, giving a net cash position of $7.14 million or $0.19 per share.

Cash & Cash Equivalents 7.56M
Total Debt 420,000
Net Cash 7.14M
Net Cash Per Share $0.19
Equity (Book Value) -7.17M
Book Value Per Share -0.24
Working Capital 1.16M
Full Balance Sheet

Cash Flow

Operating Cash Flow -21.34M
Capital Expenditures n/a
Free Cash Flow -21.34M
FCF Per Share -$0.58
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MBRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -273.43%
Shareholder Yield -273.43%
Earnings Yield -198.64%
FCF Yield -159.68%

Analyst Forecast

The average price target for MBRX is $5.00, which is 1,274.38% higher than the current price. The consensus rating is "Strong Buy".

Price Target $5.00
Price Target Difference 1,274.38%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on March 22, 2024. It was a reverse split with a ratio of 1:15.

Last Split Date Mar 22, 2024
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 1